Gut health supplement may calm inflammation in kidney dialysis patients

NCT ID NCT07694791

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether a daily capsule containing probiotics and prebiotics can lower inflammation and improve nutrition in adults with chronic kidney disease who are on peritoneal dialysis. Participants take either the synbiotic or a placebo for six months, with blood tests and checkups at the start, three months, and six months. The study measures changes in inflammation markers, gut-derived toxins, and infection rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Synbiotic (probiotics plus prebiotic fibers)
What this could lead to
If it works, this could point toward a simple, low-cost way to reduce inflammation and infection risk in people on peritoneal dialysis.
What could go wrong
This is a small, early-stage trial with only 60 participants. The supplement may not significantly lower inflammation or prevent infections, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER)

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.